|This message contains images. If you don't see images, click here to view.|
Advertise in this news brief.
|Click here to place your 2015 Proficiency Testing order or to view your previous Performance and Summary reports.
|Access to educational information is free to ASHI members. CECs are awarded through an online testing process and are free to ASHI members.
4 ASHI Travel Awards are now available!
Submit your application by Monday, Aug. 31 for your chance to win $1000 towards your travel expenses to the ASHI Annual Meeting in Savannah, Georgia, from Sept. 28-Oct. 2, 2015!
The Travel Fund Award was created to help new ASHI members attend the annual meeting. The ASHI Board of Directors recently approved 4 grants for the 2015 Annual meeting in Savannah, Georgia. Two grants have been reserved for Technologist members and two for Doctoral level members.
In order to be considered for the ASHI Travel Award, you should:
Please complete this application and return it with your CV to Katherine Miranda, Executive Director, at firstname.lastname@example.org by Monday, Aug. 31.
- Be a current ASHI member of at least the past 3 years
- Have no more than three (3) years of experience in the field
- Demonstrate volunteer service to ASHI
- Desire to further your career in HLA
| Share this article:
The ASHI 41st Annual Meeting
Savannah International Trade & Convention Center
Sept. 28-Oct. 2, 2015 in Savannah, Georgia
Make your reservation today!
Official host hotels for the annual meeting are booking quickly*.
Click here to make your reservation online today.
Register now for the annual meeting and save! Save $50 by registering by the early registration date of August 19 and save up to $135 by joining ASHI today!
Click here to register and join now!
*Westin Savannah is sold out of rooms for arrivals earlier than Monday
Banff Working Group to survey transplant programs
Following the last Banff meeting several working groups were established to prepare for the Banff 2016 meeting. The "Clinical and Laboratory Assessment of Highly Sensitized Patients Working group" elected to survey transplant programs that perform desensitization to try to understand practice variation and determine if there was an opportunity to develop recommendations regarding protocol biopsies, antibody monitoring, recipient and donor selection and treatment protocols.
The goal was to have representation from transplant clinicians, pathologists and HLA laboratory directors from as many sites as possible that perform desensitization in the US and internationally. The initial part of this process is to survey current practice. Therefore a separate survey for the clinicians, pathologist and HLA laboratories was developed. ASHI has graciously agreed to support this survey and members will receive a copy of the survey in their emails. We would appreciate you taking the time to complete the survey as it is important that we get an accurate assessment of the breadth of practice in this area and how many laboratories are performing desensitization.
MISSED AN ISSUE OF ASHI INSIGHTS? |
Click here to visit the ASHI Insights archive page.
Last week to vote!
2015 BOARD ELECTION AND PROPOSED BYLAWS AMENDMENTS BALLOT
Ballots were mailed out to full-doctoral and non-doctoral ASHI members.
The following guidelines must be followed in order for these ballots to be valid.
- Do not write your name on this ballot.
- Print and sign your name on the inside flap of the pre-addressed return envelope. If the envelope is received without this information, the ballot will be invalid.
- Place your completed ballot in the pre-addressed return envelope, seal and mail.
- To be counted, your ballot must be postmarked by Aug. 3, 2015. Ballots postmarked after that date will be invalid.
- Only the original ballot will be accepted for tabulation of votes. Ballots that have been copied or altered in any way will not be counted.
Dear ASHI Colleagues,
We are very saddened to inform you that longtime ASHI member, Dod Stewart, died unexpectedly on Friday, July 17.
Training opportunities available
We would like to remind ASHI members that a database has been set up to list those laboratories which are willing to receive visiting scientists or technologists interested in learning specific laboratory techniques. There are currently 10 laboratories that volunteered to do this.
There is no cost for the training; participants would be responsible for covering their own travel expenses while visiting the host lab.
If you or someone in your lab would like to take advantage of this unique opportunity, contact ASHI headquarters at email@example.com. Be sure to specify which technique you are interested in learning.
Call for volunteers
Please let us know if you would like to become a member of an ASHI Committee/Program. Place a mark next to each committee/program in which you are interested and indicate your preference (i.e. 1st, 2nd, 3rd). Completed forms will be used to identify volunteers to fill openings on various committees for 2016.
To be considered, please fill out the volunteer form and return your completed form to the ASHI Staff Office via fax (856-439-0525) or e-mail (firstname.lastname@example.org).
New ASHI supporter!
We are pleased to announce that mTilda has become a supporter of ASHI's educational programs.
Association between KIR gene polymorphisms and rheumatoid arthritis susceptibility: A meta-analysis
The results of studies on association between KIR (killer cell immunoglobulin-like receptors) polymorphisms and susceptibility to RA (rheumatoid arthritis) are inconsistent. To comprehensively evaluate the effect of KIR polymorphisms on the risk of RA, a meta-analysis was carried out.
HLA-matched sibling transplants provide best outcomes in infantile osteopetrosis
Clinical Endoctrinology News
Long-term survival after hematopoietic stem cell transplantation for infantile osteopetrosis was highest when grafts were taken from human leukocyte antigen (HLA)-matched siblings, according to the largest cohort of patients with the disease that has been compiled to date. For HLA-matched sibling transplants, 5- and 10-year survival probabilities were both 62 percent, whereas the combined average survival probability for HLA-mismatched relative donors, HLA-matched unrelated donors, and HLA-unmatched unrelated donors was 42 percent after 5 years and 39 percent after 10 years, Dr. Paul J. Orchard of the University of Minnesota, Minneapolis, and his colleagues reported.
High-resolution HLA typing for sensitized patients: Advances in medicine and science require us to challenge existing paradigms
American Journal of Transplantation
In the April issue of AJT, an editorial by Cecka et al commented on our personal viewpoint article wherein we proposed that HLA mismatch acceptability for sensitized transplant candidates should be determined at high-resolution levels. This editorial seems to express the view that HLA antigen-based testing be maintained as is despite its inherent deficiencies. We are perplexed by conflicting comments that more HLA complexity "should be pretty low on the list of priorities" while simultaneously mentioning a need for HLA-DQA and DP typing and "better" resolution of HLA-DRB3/4/5 types.
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063